Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market by Product, Synthesis, Application, Dosage Form, End User and Region" report has been added to ...
The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...
Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...
The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, ...
(MENAFN- IMARC Group) Setting up an API Manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw ...
The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, ...
Active Pharmaceutical Ingredients (APIs) is a substance used in a finished pharmaceutical product, intended to furnish pharmacological activity or to otherwise have direct effect in the diagnosis, ...
Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
SINGAPORE, Nov. 28, 2018 /PRNewswire/ -- ST Pharm Co Ltd was recognized with the Global API Manufacturing (Oligonucleotide) Growth Excellence Leadership award at the annual Frost & Sullivan ...
కొన్ని ఫలితాలు దాచబడ్డాయి ఎందుకంటే అవి మీకు ప్రాప్తి ఉండకపోవచ్చు.
ప్రాప్తి లేని ఫలితాలను చూపించు